Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cinnamon power: new dressing fights wound smell

NCT ID NCT05685628

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 01, 2026 · Updated 2 times

Summary

This study tests a special dressing made with cinnamon to reduce bad smells from chronic or infected wounds. About 98 adults with smelly wounds will try the dressing for 14 days. The goal is to see if it improves their quality of life by cutting down on odor discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 98 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2023

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient \>18 years of age with a smelly wound (discomfort \> 4/10 expressed by the patient); * Predictive wound healing \>14 days (clinical judgement); * Patient benefiting from a social security scheme (AME excluded) * Patient, and curator if applicable, informed and having signed the consent form for participation in the study Exclusion Criteria: * Patient who has received a secondary charcoal or cinnamon dressing within the last 48 hours * Patient with pressure ulcer stage 1 or 2 * Patient treated by metronidazole or antimicrobial for \< 3 days; * Patient who cannot communicate his feelings; * Anosmic patient; * Patient with cinnamon allergy; * Persons deprived of their liberty or under guardianship; * Inability to submit to the medical follow-up of the trial for geographical, social, psychological or cognitive reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Malodorous wounds (chronic, malignant or infected wounds) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Bronchiolitis Obliterans Syndrome Wound Infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospitalisation à Domicile AP-HP

    RECRUITING

    Paris, 75 005, France

  • Hospitalisation à domicile Fondation Santé Service

    NOT_YET_RECRUITING

    Levallois-Perret, 92 300, France

  • Hospitalisation à domicile de la région de Melun

    NOT_YET_RECRUITING

    Vaux-le-Pénil, France, 77 000, France

  • Hôpital Henri Mondor

    RECRUITING

    Créteil, 94 000, France

  • Hôpital Henri Mondor

    NOT_YET_RECRUITING

    Créteil, 94 000, France

  • Hôpital Sainte Périne

    ACTIVE_NOT_RECRUITING

    Paris, 75 016, France

  • Institut Curie

    RECRUITING

    Paris, 75 005, France